Other Lupus News

January 26, 2016

A new study led by scientists at The Scripps Research Institute (TSRI) shows how dangerous autoimmune responses, seen in diseases such as lupus and multiple sclerosis, might be “dialed down” without compromising the immune system’s ability to fight viruses and bacteria.

The new study, published in the journal Proceedings of the National Academy of Sciences, defines an unexpected mechanism at work in an anti-autoimmune drug candidate called ozanimod (now under development by Celgene).                      

January 19, 2016

A recent study showed that enteric-coated mycophenolate sodium (EC-MPS) should be considered as an alternative option to cyclophosphamide (CYC) in the treatment of lupus nephritis (LN).